ClinicalTrials.gg

Structure Therapeutics clinical trials

Also known as ShouTi.

Its pipeline, or its studies — you choose. Free with an account during the beta.

The registry lists 11 studies whose lead sponsor is Structure Therapeutics or one of 2 companies grouped under it. 4 are recruiting or about to start. Per ClinicalTrials.gov, last updated Nov 17, 2026.

Our grouping of 2 registry names, not the registry’s. See them and correct one ↓

Compare Structure Therapeutics with Novo Nordisk and Eli Lilly →

Pipeline: 2 programs

Each counted once: 2 with a study Structure Therapeutics leads registered in the last two years.

  • Phase 2
  • Phase 3

The 1 phase-3 program — sign in to see them, free: with every program, filter by condition or phase and sort by first study or primary completion.

“Registry” is the highest phase of Structure Therapeutics’ own registered studies; Structure Therapeutics’ own pipeline document is not read yet. “Primary completion” is the earliest date still ahead among its live studies when the main measure’s data collection ends, as the registry states it (most are estimates); results come later, if they are announced. Programs are read from ClinicalTrials.gov, joined across names by rules and decisions each recorded with its evidence.

What it is testing

The drugs Structure Therapeutics’ studies test, most open studies first — 1 drug with a page of their own. Each count opens the studies in search.

Open now Not open: under way, finished or stopped

Coming up

2 of Structure Therapeutics’ studies under way reach primary completion within a year. The dates are the sponsor’s own estimates, which often move.

Phase 3 Other phases

  1. N’26
  2. D
  3. J’27
  4. F
  5. 1M
  6. A
  7. M
  8. J
  9. J
  10. 1A
  11. S
  12. O
  13. N

Add all 2 to your calendar (.ics) → With an account.

What changed recently

From the registry's own updates since Oct 18, 2026.

Started recruiting1

All 11 at a glance

Where each study is in its life, its phase and its countries. Each count opens them in search.

  • Open now436%
  • Under way, not recruiting19%
  • Completed655%

Phase

  • Phase 26
  • Phase 15
  • Phase 32

Where

  • United States11

Over the years

  1. 323
  2. 24
  3. 25
  4. 326

By the year each study started. 2026 so far in the lighter column.

Registry sponsor names on this page

Our grouping. This page groups the registry's lead sponsor names by company — our grouping, not the registry's. It can be wrong or incomplete: an acquired company whose name never mentions its owner may be missing. Use “Something wrong?” under any name below to correct it.

Tell us about a missing company
No account needed. Please leave out personal details.

Each name exactly as ClinicalTrials.gov lists it, and how it relates to Structure Therapeutics.

  • Gasherbrum Bio, Inc., a wholly owned subsidiary of Structure Therapeutics
    Subsidiary
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    10 studies →
  • Aconcagua Bio, Inc. a wholly owned subsidiary of Structure Therapeutics
    Subsidiary
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    1 study →

Studies

Recruiting first, then most recently updated. Showing 11 of 11.